Customization is the New Formula in Global Pharmaceutical Packaging, Finds Frost & Sullivan
- Newer technologies will help pharmaceutical companies differentiate from competition and reduce overall packaging costs
KUALA LUMPUR, Malaysia, March 4, 2015 /PRNewswire/ -- The packaging industry plays a major role in the pharmaceutical market. It not only provides containment and drug safety but also ensures identity, convenience of handling, and proper delivery. As patent loss delivers more generics into the market, the need for packaging will steadily rise, in turn encouraging low-cost innovation in emerging markets. The demand for customization is further expected to drive the pharmaceutical packaging industry towards low-cost, sustainable and traceable packages in the future.
New analysis from Frost & Sullivan, New Technologies that will Impact the Global Pharmaceutical Packaging Industry (https://www.frost.com/p84b), finds that the United States, the European Union, and Japan account for more than 65-70 percent of the global market for pharmaceutical packaging. However, China, Brazil and India will rapidly evolve into key markets for growth and spending. Tablets and capsules will remain in demand while the use of prefilled syringes and inhalers is expected to increase owing to their ease of use and improving customization.
For complimentary access to more information on this research, please visit: http://corpcom.frost.com/forms/APAC_PR_DJeremiah_P84B-52_29Jan15.
Developed markets such as Europe have become increasingly vigilant in tracking pharmaceutical packaging and stopping drug counterfeit. By 2017, serialization of drug packages will be mandatory for all manufacturers, driving the packaging industry towards newer and unique solutions.
"Ready-for-use prototypes are expected to make waves in the pharmaceutical packaging industry," said Frost & Sullivan Healthcare Industry Manager Dr Siddharth Dutta. "Drug manufacturers can switch from existing packaging forms to more innovative designs without spending too much money on R&D."
In fact, outsourcing is seen as a strategic competitive weapon by the industry. Technical advancement in the packaging industry is slow and most pharmaceutical companies allocate only a small portion of their budget for packaging R&D, compounding the need for outsourcing.
Stronger regulatory hurdles in developed countries lead to uncertainty and further affect product innovations in the pharmaceutical packaging industry. In the face of declining R&D, the introduction of smart tag like "prooftag" from Electronic Tag Solutions is expected to alter the drug packaging landscape.
"In 2015, technologies that remind patients to take their medication and enable doctors to remotely monitor the proper use of prescribed medicines will become popular," noted Dutta. "Technologies such as radio-frequency identification and bar codes will ensure that the correct dosage is delivered to the patient, making patient management safer than ever and changing the dynamics of the global pharmaceutical packaging industry."
New Technologies that will Impact the Global Pharmaceutical Packaging Industry is part of the Life Sciences (http://www.lifesciences.frost.com) Growth Partnership Service program. Frost & Sullivan's related studies include: US Laboratory Information Management Systems (LIMS) Market, Global Stem Cell Market, and Global Infectious Disease Diagnostics Market. All studies included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.
Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.
- The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
- The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.
For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?
Contact Us: Start the discussion
Subscribe: Newsletter on "the next big thing"
Register: Gain access to visionary innovation
New Technologies that will Impact the Global Pharmaceutical Packaging Industry
P84B-52
Contact:
Donna Jeremiah
Corporate Communications – Asia Pacific
P: +61 (02) 8247 8927
F: +61 (02) 9252 8066
E: djeremiah@frost.com
Carrie Low
Corporate Communications – Asia Pacific
P: +603 6204 5910
F: +603 6201 7402
E: carrie.low@frost.com
Melissa Tan
Corporate Communications – Asia Pacific
P: +65 6890 0926
F: +65 6890 0999
E: melissa.tan@frost.com
Share this article